Overview
Monmouth Retina Consultants provides diagnostic, medical, and surgical care for diseases of the retina, vitreous, and macula across New Jersey. The practice uses advanced diagnostics and treatments, including ophthalmic endoscopy, laser interventions, and FDA-approved implants like Encelto for Macular Telangiectasia Type 2, all offered on a fee-for-service basis. It differentiates itself with a long regional presence, fellowship-trained retina specialists and vitreoretinal surgeons, a focus on complex cases, active research involvement, and the first Encelto implant in New Jersey. Its goal is to deliver comprehensive, high-quality retina care across multiple locations, advance treatment options through research, and improve outcomes for patients with serious retinal diseases.
Work here?Claim your company
Simplify's take
What believers are saying
- Monmouth Retina’s October 2026 site update shows active patient acquisition and service promotion.
- Encelto creates a new referral stream from MacTel patients seeking advanced retinal care.
- The Toms River patient coordinator posting proves ongoing operational demand across three offices.
What critics are saying
- EyeCare Partners faces a 2026 Missouri data-breach settlement, distracting management through March 2027.
- Monmouth Retina listed only one open job in September 2026, signaling restrained growth.
- If EyeCare Partners tightens spending, referral marketing, staffing, and expansion slow immediately.
What makes Monmouth Retina Consultants unique
- Monmouth Retina performed New Jersey’s first Encelto implant in 2026 for MacTel Type 2.
- Its fellowship-trained retina surgeons cover Little Silver, Manalapan, and Toms River.
- Ophthalmic endoscopy and surgical retina expertise separate it from general ophthalmology practices.
Help us improve and share your feedback! Did you find this helpful?